InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Hygromycin B Gold | Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutra... | 2022 | Med (N Y) | Duty J.A. et al. | DOI: 10.1016/j.medj.2022.08.002 |
| G418 (Geneticin) | Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutra... | 2022 | Med (N Y) | Duty J.A. et al. | DOI: 10.1016/j.medj.2022.08.002 |
| Zeocin® | Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutra... | 2022 | Med (N Y) | Duty J.A. et al. | DOI: 10.1016/j.medj.2022.08.002 |
| pCpGfree-promoter | Identification of TMEM129, encoding a ubiquitin-protein ligase, as an effecto... | 2022 | Arthritis Res Ther. | Brumwell A. et al. | DOI: 10.1186/s13075-022-02882-y |
| Normocin® - Antimicrobial Reagent | Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagemen... | 2022 | Front Pharmacol | Guzelj S. & Jakopin Z. | DOI: 10.3389/fphar.2022.920928 |
| HEK-Blue™ hNOD1 | Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagemen... | 2022 | Front Pharmacol | Guzelj S. & Jakopin Z. | DOI: 10.3389/fphar.2022.920928 |
| C12-iE-DAP | Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagemen... | 2022 | Front Pharmacol | Guzelj S. & Jakopin Z. | DOI: 10.3389/fphar.2022.920928 |
| Zeocin® | Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagemen... | 2022 | Front Pharmacol | Guzelj S. & Jakopin Z. | DOI: 10.3389/fphar.2022.920928 |
| Blasticidin | Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagemen... | 2022 | Front Pharmacol | Guzelj S. & Jakopin Z. | DOI: 10.3389/fphar.2022.920928 |
| Rat IgG2a Control | Synthesis of bioactive (1→6)-β-glucose branched poly-amido-saccharides that s... | 2022 | Nat Commun. | Xiao R. et al. | DOI: 10.1038/s41467-022-32346-5 |
| Curdlan | Synthesis of bioactive (1→6)-β-glucose branched poly-amido-saccharides that s... | 2022 | Nat Commun. | Xiao R. et al. | DOI: 10.1038/s41467-022-32346-5 |
| RAW-Blue™ Cells | Synthesis of bioactive (1→6)-β-glucose branched poly-amido-saccharides that s... | 2022 | Nat Commun. | Xiao R. et al. | DOI: 10.1038/s41467-022-32346-5 |
| Anti-mouse Dectin-1 (CLEC7A) antibody | Synthesis of bioactive (1→6)-β-glucose branched poly-amido-saccharides that s... | 2022 | Nat Commun. | Xiao R. et al. | DOI: 10.1038/s41467-022-32346-5 |
| Pam3CSK4 | Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Respons... | 2022 | J Innate Immun. | Jansen A. et al. | DOI: 10.1159/000525572 |
| Poly(I:C) HMW | Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Respons... | 2022 | J Innate Immun. | Jansen A. et al. | DOI: 10.1159/000525572 |
| ODN M362 - TLR9 ligand | Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Respons... | 2022 | J Innate Immun. | Jansen A. et al. | DOI: 10.1159/000525572 |
| R848 (Resiquimod) | Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Respons... | 2022 | J Innate Immun. | Jansen A. et al. | DOI: 10.1159/000525572 |
| IFN-α/β Reporter HEK 293 Cells | CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cell... | 2022 | Viruses | Kedarinath K. et al. | DOI: 10.3390/v14081735 |
| QUANTI-Blue™ | CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cell... | 2022 | Viruses | Kedarinath K. et al. | DOI: 10.3390/v14081735 |
| Blasticidin | CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cell... | 2022 | Viruses | Kedarinath K. et al. | DOI: 10.3390/v14081735 |